Michael H. Davidson - 29 Dec 2023 Form 3/A Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Executive Officer, Director
Signature
/s/ Louise Kooij by Power of Attorney for Michael H. Davidson
Issuer symbol
NAMS
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
3/A
Filing time
25 Jan 2024, 17:00:09 UTC
Date Of Original Report
29 Dec 2023
Previous filing
10 Jun 2022
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAMS Warrant (right to buy) 29 Dec 2023 Ordinary Shares 100,000 $11.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to include warrants to purchase ordinary shares inadvertently omitted from the Form 3 filed by the Reporting Person on December 29, 2023.